VRNA

Verona Pharma
VRNA

Overview Fund Trends Analyst Outlook
Delisted

VRNA was delisted on the 6th of October, 2025.

Back to rankings

68 hedge funds and large institutions have $474M invested in Verona Pharma in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+28
Holders Change %
+70%
% of All Funds
1.18%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.12%
New
35
Increased
15
Reduced
7
Closed
6
Calls
$5.57M
Puts
$1.89M
Net Calls
+$3.67M
Net Calls Change
+$3.29M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$28.9M
2
PA
Perceptive Advisors
New York
+$21.8M
3
FLSM
Frazier Life Sciences Management
California
+$21.5M
4
FFM
Fairmount Funds Management
Pennsylvania
+$17.9M
5
VC
Vivo Capital
California
+$15.3M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$3.19M
2
TCM
Tekla Capital Management
Massachusetts
-$3.15M
3
SB
Samsara BioCapital
California
-$1.76M
4
WP
Woodline Partners
California
-$1.29M
5
VP
venBio Partners
California
-$678K
Name Holding Trade Value Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$61.8M +$9.71M +950,000 +19%
NMC
2
NEA Management Company
Maryland
$57.1M +$4.87M +476,190 +9%
PA
3
Perceptive Advisors
New York
$51.6M +$21.8M +2,132,118 +73%
VC
4
Vivo Capital
California
$43.4M +$15.3M +1,500,000 +55%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$42.7M +$3.57M +349,127 +9%
DTC
6
Deep Track Capital
Connecticut
$28.9M +$28.9M +2,829,094 New
FFM
7
Fairmount Funds Management
Pennsylvania
$27.4M +$17.9M +1,752,380 +189%
A
8
Abingworth
United Kingdom
$25.1M – – –
FLSM
9
Frazier Life Sciences Management
California
$21.5M +$21.5M +2,099,541 New
ACM
10
Aisling Capital Management
New York
$13.6M – – –
OCA
11
Octagon Capital Advisors
New York
$13.5M +$13.5M +1,324,868 New
FCMI
12
Foresite Capital Management III
California
$11.4M – – –
SB
13
Samsara BioCapital
California
$9.6M -$1.76M -172,222 -15%
Citadel Advisors
14
Citadel Advisors
Florida
$7.11M +$7M +684,511 +6,368%
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$6.14M +$6.14M +600,000 New
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.41M +$4.41M +431,816 New
State Street
17
State Street
Massachusetts
$4.23M +$4.23M +449,029 New
Fidelity Investments
18
Fidelity Investments
Massachusetts
$4.22M +$4.22M +413,400 New
ACM
19
Altium Capital Management
New York
$4.13M +$4.13M +404,000 New
WP
20
Woodline Partners
California
$3.83M -$1.29M -126,425 -25%
Two Sigma Investments
21
Two Sigma Investments
New York
$3.69M +$3.69M +360,550 New
AAA
22
Affinity Asset Advisors
New York
$3.58M +$3.58M +350,000 New
PHP
23
Parkman Healthcare Partners
Connecticut
$3.3M +$3.3M +323,273 New
ECM
24
ExodusPoint Capital Management
New York
$2.45M +$2.45M +239,602 New
MAP
25
Moody Aldrich Partners
Massachusetts
$2.33M +$2.33M +227,989 New
1
2 3